Clinical Trials Logo

Clinical Trial Summary

A retrospective observational study of the effectiveness of gemcitabine - docetaxel in patients with relapsed osteosarcoma who have been treated with HD IFO in first line treatment


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04651179
Study type Observational
Source Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna
Contact
Status Completed
Phase
Start date April 24, 2020
Completion date November 23, 2021

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03628209 - Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable Osteosarcoma Phase 1/Phase 2
Completed NCT04651569 - An Analysis of the Efficacy of High Dose Isofosfamide Through Elastomer
Recruiting NCT04417062 - Olaparib With Ceralasertib in Recurrent Osteosarcoma Phase 2
Active, not recruiting NCT04803877 - SARC038: Phase 2 Study of Regorafenib and Nivolumab in Osteosarcoma Phase 2
Not yet recruiting NCT06465199 - Difluoromethylornithine (DFMO) and AMXT-1501 for Neuroblastoma, CNS Tumors, and Sarcomas Phase 1/Phase 2